Company completes Jennie-O whole bird sale and shifts toward value-added protein portfolio

USA – Hormel Foods Corporation has confirmed it is withdrawing from commodity poultry operations as it redirects its protein strategy toward branded turkey products that align with changing consumer demand and its focus on higher-value packaged foods.
The update was outlined by President John Ghingo and Interim Chief Financial Officer Paul Kuehneman during the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference, where the company detailed its revised approach to poultry and protein categories.
Ghingo said consumers are increasingly prioritising higher protein intake throughout the day, including during breakfast and snacking, as demand grows for convenient products that deliver satiety and sustained energy with simplified nutrition choices.
The company confirmed it completed the sale of Jennie-O’s whole bird turkey business to Life-Science Innovations in April 2026, marking a structural change in its poultry operations and narrowing its exposure within the broader turkey segment.
Ghingo said the whole-bird segment delivered high volumes but showed significant year-to-year fluctuations in pricing and performance, making it less compatible with the company’s long-term move toward more stable growth in branded products.
Following the transaction, Hormel’s turkey business will remain focused on branded products, with Jennie-O positioned as a priority label, supported by continued investment, given steady consumption trends in packaged protein categories.
Kuehneman said the restructuring also reduces exposure to volatility in input costs across protein markets, with pork, beef and poultry raw material prices remaining elevated near five-year highs and continuing to pressure margins across the sector.
The company identified three main consumption occasions driving demand for lean poultry, including morning meals where protein is replacing carbohydrate-heavy foods, daytime snacking centred on convenience, and quick dinner solutions focused on speed and nutrition.
Ghingo also pointed to the growing segment of consumers using GLP-1 medications, noting that their preference for high-protein and high-fibre foods overlaps with broader shifts in health-driven eating patterns across multiple consumer groups.
Hormel said its future strategy will continue to focus on branded protein products shaped around evolving eating habits, with an emphasis on convenience, nutritional density, and categories expected to deliver more consistent long-term growth.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.